[The Chediak-Higashi syndrome. Description of a case and recent etiopathogenetic acquisitions].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D002609:Chediak-Higashi Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007223:Infant; D007962:Leukocytes / Q000648:ultrastructure; D008214:Lymphocytes / Q000648:ultrastructure; D008297:Male; D008854:Microscopy, Electron; D009461:Neurologic Manifestations; D013156:Splenectomy; D013449:Sulfonamides / Q000627:therapeutic use; D005719:gamma-Globulins / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D005938:Glucocorticoids; D007136:Immunoglobulins; D013449:Sulfonamides; D005719:gamma-Globulins; D000324:Adrenocorticotropic Hormone
La sindrome di Chediak-Higashi. Descrizione di un caso e recenti acquisizioni eziopatogenetiche